(Q45876668)

17 December 2017

title

Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodies (English)

1 reference

17 December 2017

1 reference

1 reference

M Särkioja

1

1 reference

17 December 2017

S Pesonen

2

1 reference

17 December 2017

M Raki

3

1 reference

17 December 2017

T Hakkarainen

4

1 reference

17 December 2017

J Salo

5

1 reference

17 December 2017

M T Ahonen

6

1 reference

17 December 2017

A Kanerva

7

1 reference

17 December 2017

A Hemminki

8

1 reference

17 December 2017

publication date

10 April 2008

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

15

1 reference

17 December 2017

page(s)

921-929

1 reference

17 December 2017

issue

12

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/gt.2008.56

exact match

0 references

cites work

AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Clinical trials with oncolytic adenovirus in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Gene transfer approaches for gynecological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Current strategies and future directions for eluding adenoviral vector immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Systemic efficacy of oncolytic adenoviruses in imagable orthotopic models of hormone refractory metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

The influence of blood on in vivo adenovirus bio-distribution and transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Specific depletion of human anti-adenovirus antibodies facilitates transduction in an in vivo model for systemic gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Adenoviruses for treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Infectivity-enhanced adenoviruses deliver efficacy in clinical samples and orthotopic models of disseminated gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Noninvasive imaging for evaluation of the systemic delivery of capsid-modified adenoviruses in an orthotopic model of advanced lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Serum and ascites neutralizing antibodies in ovarian cancer patients treated with intraperitoneal adenoviral gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Adenovirus type 41 lacks an RGD alpha(v)-integrin binding motif on the penton base and undergoes delayed uptake in A549 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

A canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Imaging of angiogenesis: from microscope to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Role of heparan sulfate in immune system-blood vessel interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Genetically targeted adenovirus vector directed to CD40-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Development and assessment of human adenovirus type 11 as a gene transfer vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

Pre-existent adenovirus antibody inhibits systemic toxicity and antitumor activity of CN706 in the nude mouse LNCaP xenograft model: implications and proposals for human therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

inferred from DOI database lookup

7 January 2021

based on heuristic

Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

inferred from DOI database lookup

7 January 2021

based on heuristic

Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.56

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2008.56

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017